Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.
Tatiana Schlossberg, the daughter of Caroline Kennedy, has died following a battle with acute myeloid leukemia.
News-Medical.Net on MSN
Combination therapy offers hope for AML patients facing drug resistance
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...
Compared with white patients, Black patients with acute myeloid leukemia (AML) were on average more than five years younger at diagnosis, more than 30% more likely to die of their disease, and more ...
Black race is an independent prognostic factor for lower survival outcomes in AML, regardless of cytogenetics. Black patients with NPM1 mutations had poorer overall survival compared to White patients ...
Compared with white patients, Black patients with acute myeloid leukemia (AML) were on average more than five years younger at diagnosis, more than 30% more likely to die of their disease, and more ...
Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...
The approval was based on data from the single-arm, open-label phase 2 KOMET-001 trial, which evaluated ziftomenib, a menin inhibitor, in adults with R/R AML with an NPM1 mutation.
The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted therapies, the promise of off-the-shelf chimeric antigen receptor (CAR) ...
US Weekly on MSN
Inside Tatiana Schlossberg’s Cancer Battle With Acute Myeloid Leukemia Before Her Death at Age 35
Tatiana Schlossberg opened up in a New Yorker essay about terminal acute myeloid leukemia and missing time with her children ...
Tatiana Schlossberg, a journalist and granddaughter of President John F. Kennedy, has died at 35 after a battle with cancer, ...
A newly identified and rare genetic variant slows the growth of mutated blood stem cells and reduces the risk of leukemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results